MiroBio Overview
- Year Founded
-
2018
- Status
-
Acquired/Merged
- Employees
-
30
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$414M
- Investors
-
1
MiroBio General Information
Description
Developer of novel therapeutics technology designed to bring significant benefits to patients suffering from a range of auto-immune diseases. The company's therapeutics activate natural mechanisms to regain control of overactive immune responses triggering these diseases and leverage natural signaling mechanisms to restore immune system balance and control, enabling clinicians to treat autoimmune diseases.
Contact Information
Website
www.mirobio.comCorporate Office
- Winchester House, Heatley Road
- Oxford Science Park
- Oxford OX4 4GE
- England, United Kingdom
Corporate Office
- Winchester House, Heatley Road
- Oxford Science Park
- Oxford OX4 4GE
- England, United Kingdom
MiroBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 20-Sep-2022 | $414M | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series B) | 29-Jun-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 07-Oct-2019 | $33.5M | $33.5M | Completed | Generating Revenue | |
| 1. University Spin-Out | 08-Oct-2018 | Completed | Startup |
MiroBio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
MiroBio Comparisons
Industry
Financing
Details
MiroBio Competitors (43)
One of MiroBio’s 43 competitors is Navrogen, a Venture Capital-Backed company based in Cheyney, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Navrogen | Venture Capital-Backed | Cheyney, PA | ||||
| Mestag Therapeutics | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| Macomics | Venture Capital-Backed | Edinburgh, United Kingdom | ||||
| NovaBiotics | Venture Capital-Backed | Aberdeen, United Kingdom | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA |
MiroBio Patents
MiroBio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026053130-A1 | Anti-btla antibodies and uses of the same | Pending | 03-Sep-2024 | ||
| AU-2023251091-A1 | Engineered cd200r antibodies and uses thereof | Pending | 06-Apr-2022 | ||
| AU-2023251091-A2 | Engineered cd200r antibodies and uses thereof | Pending | 06-Apr-2022 | ||
| EP-4504786-A1 | Engineered cd200r antibodies and uses thereof | Pending | 06-Apr-2022 | ||
| US-20230416361-A1 | Engineered cd200r antibodies and uses thereof | Pending | 06-Apr-2022 | C07K16/2803 |
MiroBio Signals
MiroBio Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Advent Life Sciences | Venture Capital | Minority | ||
| Medicxi Ventures (UK) | Venture Capital | Minority | ||
| Monograph Capital | Venture Capital | Minority | ||
| OrbiMed | Growth/Expansion | Minority | ||
| Oxford Science Enterprises | Venture Capital | Minority |
MiroBio FAQs
-
When was MiroBio founded?
MiroBio was founded in 2018.
-
Where is MiroBio headquartered?
MiroBio is headquartered in Oxford, United Kingdom.
-
What is the size of MiroBio?
MiroBio has 30 total employees.
-
What industry is MiroBio in?
MiroBio’s primary industry is Biotechnology.
-
Is MiroBio a private or public company?
MiroBio is a Private company.
-
What is the current valuation of MiroBio?
The current valuation of MiroBio is .
-
What is MiroBio’s current revenue?
The current revenue for MiroBio is .
-
How much funding has MiroBio raised over time?
MiroBio has raised $130M.
-
Who are MiroBio’s investors?
Advent Life Sciences, Medicxi Ventures (UK), Monograph Capital, OrbiMed, and Oxford Science Enterprises are 5 of 7 investors who have invested in MiroBio.
-
Who are MiroBio’s competitors?
Navrogen, Mestag Therapeutics, Macomics, NovaBiotics, and Inovio Pharmaceuticals are some of the 43 competitors of MiroBio.
-
When was MiroBio acquired?
MiroBio was acquired on 20-Sep-2022.
-
Who acquired MiroBio?
MiroBio was acquired by Gilead.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process